These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 18220545)
1. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Bhargava S; Agrawal GP Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545 [TBL] [Abstract][Full Text] [Related]
2. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity. Yurtdaş-Kırımlıoğlu G Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation. Semalty M; Panchpuri M; Singh D; Semalty A Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeae. Schaadt RD; Yagi BH; Zurenko GE Antimicrob Agents Chemother; 1990 Feb; 34(2):371-2. PubMed ID: 2109583 [TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer. Gundogdu E; Koksal C; Karasulu E Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
8. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A. Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811 [TBL] [Abstract][Full Text] [Related]
9. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Guo B; Zhong S; Li N; Li X; Yi J; Jin M Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation, Giri BR; Lee J; Lim DY; Kim DW Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707 [TBL] [Abstract][Full Text] [Related]
11. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization. Sherje A; Londhe V Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059 [TBL] [Abstract][Full Text] [Related]
12. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin. Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034 [TBL] [Abstract][Full Text] [Related]
13. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes. Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of lyophilized cefpodoxime proxetil-Pluronic Yurtdaş-Kırımlıoğlu G Pharm Dev Technol; 2021 Apr; 26(4):476-489. PubMed ID: 33616480 [TBL] [Abstract][Full Text] [Related]
15. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
16. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement. Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809 [TBL] [Abstract][Full Text] [Related]
17. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
19. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties. Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120 [TBL] [Abstract][Full Text] [Related]
20. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios. Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]